Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Galunisertib
Trade Name
Synonyms LY2157299|LY-2157299
Drug Descriptions

Galunisertib (LY2157299) is a TGFBR1 antagonist, which inhibits downstream signaling and may suppress tumor growth (PMID: 18039567, PMID: 32210440).

DrugClasses TGFBR1 inhibitor 16
CAS Registry Number 700874-72-2
NCIT ID C116891


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abemaciclib + Galunisertib Abemaciclib Galunisertib 0 1
Capecitabine + Galunisertib Capecitabine Galunisertib 0 2
Carboplatin + Galunisertib + Paclitaxel Carboplatin Galunisertib Paclitaxel 0 1
Durvalumab + Galunisertib Durvalumab Galunisertib 0 1
Fluorouracil + Galunisertib Fluorouracil Galunisertib 0 1
Galunisertib Galunisertib 0 6
Galunisertib + Paclitaxel Galunisertib Paclitaxel 0 1
Galunisertib + Sorafenib Galunisertib Sorafenib 0 1

Additional content available in CKB BOOST